ENDOTHELIAL CELL MICROPARTICLES-DELIVERY MIR-155 PROMOTES THE DEVELOPMENT OF AGVHD BY MODULATING T CELLS

EHA Library, Qiuling Wu, 100834

PRESENCE OF KIR2DS1 RECEPTOR IN DONORS OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION DUE TO MYELOID MALIGNANCIES IMPROVES OVERALL SURVIVAL IN RECIPIENTS WITH HLA-C2 ANTIGENS

EHA Library, Attila Tordai, 100835

ENDOTHELIAL MICROPARTICLE IS INVOLVED IN THE DEVELOPMENT OF ACUTE GVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Mei Hong, 100836

SIMPLE, EFFICIENT, AND SAFE PROCESSING OF FROZEN-THAWED UMBILICAL CORD-DERIVED MESENCHYMAL STROMAL CELLS APPLIED FOR THE TREATMENT OF GVHD

EHA Library, Tokiko Nagamura-Inoue, 100837

THE IMPACT OF NFAT INHIBITION ON NEUTROPHIL EFFECTOR FUNCTIONS IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Daniel Teschner, 100838

INHIBITION OF TRANSFORMING GROWTH FACTOR ΒETA-ACTIVATED KINASE 1 SUPPRESSES ALLOREACTIVITY AND IMPROVES SURVIVAL IN A MURINE MARROW TRANSPLANTATION MODEL

EHA Library, Ayako Kobayashi, 100839

DISTINCT EXOSOMAL MIRNA EXPRESSION OF LATE ONSET GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Seiichiro Yoshizawa, 100840

B LYMPHOCYTES ARE IMPORTANT EFFECTOR CELLS IN ANTI-AML RESPONSES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Marijn Gillissen, 100841

FEMUR TARGET CELL TRANSPLANTATION CAN BE ACHIEVED BY MAGNETISM-INDUCED CELL TARGET TRANSPLANTATION (MAGIC-TT) IN MURINE TRANSPLANTATION MODEL

EHA Library, Hao Huang, 100842

COMPLEMENT-BINDING DONOR-SPECIFIC ANTI-HLA ANTIBODIES AND RISK OF PRIMARY GRAFT FAILURE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Stefan Ciurea, 100843

DURABLE REMISSIONS AFTER SEQUENTIAL TRANSPLANTATION USING T-REPLETE NON-MYELOABLATIVE CONDITIONING FOR RELAPSED/ REFRACTORY ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA

EHA Library, Sandra hassan, 100844

SERUM FERRITIN IS INDEPENDENT OF DISEASE RISK INDEX FOR OVERALL SURVIVAL FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Lynette Chee, 100845

COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE

EHA Library, Lenneke van groningen, 100846

PURE RED CELL APLASIA IN MAJOR ABO MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS ASSOCIATED WITH SEVERE PANCYTOPENIA

EHA Library, Fleur Aung, 100847

DONOR CHIMERISM AS MARKER OF RELAPSES AFTER BONE MARROW TRANSPLANTATION.

EHA Library, Ildar Barkhatov, 100848

PERIPHERAL BLOOD EOSINOPHIL COUNT AT DAY 28 AS A PROGNOSTIC INDICATOR IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Keisuke Kawamoto, 100849

AUTOLOGOUS STEM CELL TRANSPLANTATION WITH HIGH-DOSE MITOXANTRONE AND MELPHALAN IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA : LONG-TERM SURVIVAL AND TOXICITY DATA

EHA Library, Yener Koc, 100850

RISK FACTORS FOR TRANSPLANTATION-ASSOCIATED THROMBOTIC MICROANGIOPATHY AND OUTCOME OF PATIENTS, FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Katalin Balassa, 100851

REITERATED THERAPEUTIC DRUG MONITORING (TDM) TO BETTER CONTROL TARGETED EXPOSURE TO IV BUSULFAN IN INFANTS AND OLDER CHILDREN UNDERGOING HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT)

EHA Library, Alexandre Amin, 100852

FACTORS DETERMINING THE EFFECTIVENESS OF ACUTE GRAFT VERSUS HOST DISEASE PROPHYLAXIS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION WITH MULTIPOTENT MESENCHYMAL STROMAL CELLS

EHA Library, Nataliya Petinati, 100853

IMPACT OF HISTOLOGIC GRADE ON THE OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMAS

EHA Library, Paolo Corradini, 100854

ALPHA/BETA T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION FROM MATCHED RELATED AND UNRELATED DONOR GRAFTS IN PATIENTS WITH HIGH RISK HEMATOLOGICAL MALIGNANCIES.

EHA Library, Moniek de Witte, 100855

OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH MDS/MPN OVERLAP SYNDROMES- A SINGLE INSTITUTIONAL EXPERIENCE.

EHA Library, Shivani Shinde, 100856

FEASIBILITY OF LENALIDOMIDE MAINTENANCE AFTER NONMYELOABLATIVE ALLOGENEIC TRANSPLANTATION (NMAT) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).

EHA Library, Issa Khouri, 100857

ENGRAFTMENT SYNDROME (ES) AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: A HIGH INCIDENCE IN HAPLOIDENTICAL SETTING

EHA Library, Yao Chen, 100858

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR + G-CSF VS PLACEBO + G-CSF TO MOBILIZE ≥5 X 106 CD34+ CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION

EHA Library, Jun Zhu, 100859

INFLUENCE OF CYP3A5 GENE POLYMORPHISMS ON PHARMACOKINETICS OF TACROLIMUS MODIFIED-RELEASE ONCE-DAILY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Takaya Yamashita, 100860

INTERFERONΑ: A POTENTIAL EFFECTIVE TREATMENT FOR MINIMAL RESIDUAL DISEASE IN ACUTE LEUKEMIA/MYELODYSPLASTIC SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Dong Mo, 100862

INCIDENCE, RISK FACTORS, AND OUTCOME OF EARLY HEMOSTATIC COMPLICATIONS IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE MULTICENTER STUDY OF 551 PATIENTS

EHA Library, Yue Han, 100863

A PROSPECTIVE CLINICAL TRIAL OF PROLONGED AUTOLOGOUS ERYTHROPOIETIN (EPO) SECRETION FROM TARGTEPO IN EPO-DEPENDENT END STAGE RENAL DISEASE PATIENTS SHOWED EPO INDEPENDENCE FOR OVER 8 MONTHS

EHA Library, Shany Blum, 100864

ADOPTIVE IMMUNOTHERAPY OF MULTIPLE MYELOMA (MM) WITH ALLOGENIC CAR T-CELLS TARGETING CS1: ENHANCEMENT OF CAR ACTIVITY THROUGH CS1 GENE INACTIVATION IN EFFECTOR CELLS

EHA Library, Roman Galetto, 100865

EVALUATING HUMAN T-CELL THERAPY OF CYTOMEGALOVIRUS ORGAN DISEASE IN HLA-TRANSGENIC MICE

EHA Library, Simone Thomas, 100866

NOVEL HUMAN IL-15 SUPERAGONIST PROMOTES LONG-TERM PERSISTENCE AND REACTIVITY OF HUMAN EBV- AND LEUKEMIA-SPECIFIC CD8+ T CELLS WITH STEM CELL MEMORY AND CENTRAL MEMORY PROPERTIES IN HUMANIZED MICE.



EHA Library, Udo Hartwig, 100867

DENDRITIC CELL VACCINATION IN POSTREMISSION THERAPY OF AML: RESULTS OF A CLINICAL PHASE I TRIAL AND OF PRECLINICAL STUDIES TESTING COMBINATORIAL APPROACHES

EHA Library, Marion Subklewe, 100868

COMBINATION OF IBRUTINIB AND ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF RELAPSING/REFRACTORY MANTLE CELL LYMPHOMA (MCL)

EHA Library, Marco Ruella, 100869

INTERIM ANALYSIS OF PHASE I/II TRIAL IN HIGH-RISK PEDIATRIC PATIENTS POST ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) TREATED WITH EX VIVO EXPANDED DONOR-DERIVED ADENOVIRUS-SPECIFIC T CELLS

EHA Library, Winnie Ip, 100870

LIPOSOME-BASED SPECIFIC TARGETING OF A STAT3-INHIBITOR TO CANCER-PROMOTING MACROPHAGES: A NOVEL THERAPUTIC PARADIGM IN MULTIPLE MYELOMA

EHA Library, Morten Nørgaard Andersen, 100871

ANTIBODY-TARGETED CYCLODEXTRIN NANOPARTICLES DELIVER SIRNA AND ACHIEVE THERAPEUTIC GENE SILENCING IN BLOOD FROM ACUTE MYELOID LEUKAEMIA (AML) PATIENTS

EHA Library, Jianfeng Guo, 100872

CLINICAL GRADE ACTIVATED NATURAL KILLER PRODUCTS FOR ADOPTIVE IMMUNOTHERAPY AGAINST HIGH-RISK MALIGNANCIES

EHA Library, Antonio Perez, 100873

IMPROVED SAFETY AND EFFICACY OF A HIGH-AFFINITY A2.1-RESTRICTED SINGLE-CHAIN P53-SPECIFIC TCR FOR ADOPTIVE IMMUNOTHERAPY

EHA Library, Hakim Echchannaoui, 100874

HYDROXYUREA FOR Β-THALASSEMIA: A META-ANALYSIS

EHA Library, Ali Algiraigri, 100875

PHENOTYPIC VARIATIONS IN SICKLE CELL DISEASE: AN EXPLORATION OF THE ROLE OF THE ENVIRONMENT AND SKIN MICROBIOME ON LEG ULCERS

EHA Library, Caterina Minniti, 100876

PERICARDIAL EFFUSION IS A MARKER OF INCREASED CARDIAC MORTALITY IN THALASSEMIA MAJOR PATIENTS

EHA Library, Alessia Pepe, 100877

OUTCOMES OF A COHORT OF CHILDREN WITH HEMOGLOBINOPATHY RECEIVING ORAL IRON CHELATORS FOR TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN TURKEY: RESULTS OF 3-YEAR FOLLOW-UP STUDY

EHA Library, Ali Bülent Antmen, 100878

RARE INHERITED ANAEMIAS: A CLINICAL-GRADE VALIDATED TARGETED RESEQUENCING PANEL YIELDS HIGH DIAGNOSTIC RATES AND IMPROVES TARGETED MANAGEMENT

EHA Library, Noemi , 100879

A PROSPECTIVE CROSS-SECTIONAL STUDY ON OPTHALMOLOGIC COMPLICATIONS AMONG PATIENTS WITH SICKLE CELL DISEASE IN LEBANON

EHA Library, Adlette Inati, 100880

PREVALENCE OF G6PD DEFICIENCY IN PATIENTS WITH SICKLE CELL DISEASE AND IMPACT ON DISEASE SEVERITY IN LEBANON

EHA Library, Adlette Inati, 100881

ANTIFUNGAL PROPHYLAXIS IN HAEMATOLOGY PATIENTS: FREQUENCY AND DRUG CLASS OF CHOICE ACCORDING TO TYPE OF HAEMATOLOGICAL MALIGNANCY (AFHEM STUDY)

EHA Library, Mauricette Michallet, 100882

INVESTIGATING CYTOPENIA MAY REVEAL BONE MARROW METASTASIS: A SINGLE CENTER EXPERIENCE FROM THE HEMATOPATHOLOGIST POINT OF VIEW

EHA Library, Ambra Paolini, 100883

DORIPENEM VERSUS MEROPENEM AS THE FIRST-LINE MONO-THERAPY IN HIGH-RISK FEBRILE NEUTROPENIC PATIENTS WITH ACUTE LEUKEMIA: A RANDOMIZED, CONTROLLED TRIAL

EHA Library, Norifumi Sugawara, 100884

THE RATE OF HUMAN HERPES VIRUS 6 INFECTION IN ACUTE LEUKEMIA AND LYMPHOMA PATIENTS

EHA Library, Tatiana Lobanova, 100885

IMPACT OF DECTIN-1 POLYMORPHISMS ON SUSCEPTIBILITY OF INVASIVE FUNGAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Mike Fischer, 100886

ANTIFUNGAL PROPHYLAXIS WITH POSACONAZOLE IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY. A MULTICENTER RETROSPECTIVE STUDY OF REAL-LIFE PRACTICE

EHA Library, David Serrano, 100887

COMMUNITY ACQUIERED RESPIRATORY VIRUS IN ADULTS PATIENTS WITH HEMATOLOGICAL DISEASE: CLINICAL CHARACTERISTICS AND OUTCOME IN RSV AND HPIV INFECTION

EHA Library, ALICIA LORENZO JAMBRINA, 100888

LEVEL OF PENTRAXIN-3 IN PATIENTS WITH ACUTE LEUKEMIA IN SEPTICEMIA AND ITS PROGNOSTIC VALUE

EHA Library, Mohamed El-defrawy, 100889

IDENTIFICATION OF CLONALITY IN IDIOPATHIC HYPEREOSINOPHILIA USING TARGETED EXOME SEQUENCING

EHA Library, Jee-Soo Lee, 100890

DEVELOPMENT OF A NOVEL ANTI-NEUTROPENIC FACTOR CLINICAL CANDIDATE FOR HEMATOPOIESIS DEFICIENCIES

EHA Library, Ronald Jubin, 100891

PRECLINICAL PHARMACOKINETIC/PHARMACODYNAMIC RELATIONSHIPS FOR AG-348, AN INVESTIGATIONAL SMALL-MOLECULE ACTIVATOR OF PYRUVATE KINASE

EHA Library, Yue Chen, 100892

EFFICACY AND SAFETY OF ELTROMBOPAG IN PATIENTS WITH MODERATE, SEVERE AND VERY SEVERE APLASTIC ANEMIA

EHA Library, Danielle Nance, 100893

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: SINGLE CENTER EXPERIENCE

EHA Library, Ersin Toret, 100894

MANAGEMENT OF CYCLIC NEUROPENIA: DIAGNOSIS AND THERAPY

EHA Library, Cornelia Zeidler, 100895

RELATION BETWEEN GLUTATHIONE S TRANSFERASE GENES (GSTM1, GSTT1 AND GSTP1) POLYMORPHISMS AND CLINICAL MANIFESTATIONS OF SICKLE CELL DISEASE IN EGYPTIAN PATIENTS

EHA Library, Hend Ellithy, 100896

CASES OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS:A SINGLE CENTER EXPERIENCE.

EHA Library, Serap Karaman, 100897

MYCHOPHENOLATE MOFETIL AND SIROLIMUS AS TREATMENT OF AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE IN CHILDREN: A SINGLE CENTER EXPERIENCE

EHA Library, Maurizio Miano, 100898

ADULT DISSEMINATED LANGERHANS CELL HISTIOCYTOSIS IN THE US: A POPULATION-BASED STUDY USING THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM

EHA Library, Ronald Go, 100899

MULTICENTRE OBSERVATIONAL PROSPECTIVE COHORT STUDY LOOKING AT CARDIOVASCULAR RISK AND PURE RED CELL APLASIA ASSOCIATED WITH EPOETIN THETA IN 1039 PATIENTS WITH CHRONIC KIDNEY DISEASE

EHA Library, Andreas Lammerich, 100900

ADJUSTED CORTICOSTEROID RISK FUNCTION OF SEVERE INFECTION IN PRIMARY IMMUNE THROMBOCYTOPENIA ADULTS. A NATIONWIDE NESTED CASE-CONTROL STUDY.

EHA Library, Guillaume Moulis, 100901

ELTROMBOPAG SAFETY AND EFFICACY FOR PRIMARY CHRONIC IMMUNE THROMBOCYTOPENIA IN CLINICAL PRACTICE

EHA Library, Tomás José González-López, 100902

IDENTIFICATION OF B CELL SUBSETS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Eva Schippers, 100903

BETA2 GLYCOPROTEIN I EXPRESSION IN MONOCYTES IS DECREASED IN IMMUNE THROMBOCYTOPAENIA AND REGULATED BY IL-6

EHA Library, Xiaohui Zhang, 100904

THE UNITED KINGDOM IMMUNE THROMBOCYTOPENIA (UK ITP) REGISTRY: PRELIMINARY FINDINGS ON BLEEDING EVENTS EXPERIENCED BY ITS PARTICIPANTS.

EHA Library, Umesh Doobaree, 100905

THYROID DYSFUNCTION IN IMMUNE THROMBOCYTOPENIA: MORE THAN AN ASSOCIATION

EHA Library, Mukul Aggarwal, 100906

ELEVATED SERUM THROMBOPOIETIN LEVEL IN IMMUNE THROMBOCYTOPENIA IN PREGNANCY

EHA Library, Yuanxin Sun, 100907

CHRONIC IMMUNE THROMBOCYTOPENIA IN CHILDHOOD: EVALUATION OF THE DATA OVER 30 YEARS BASED ON THE REVISED CRITERIA OF INTERNATIONAL WORKING GROUP

EHA Library, Begum Koc, 100908

RESPONSE LOSS AND DEVELOPMENT OF NEUTRALIZING ANTIBODIES DURING LONG-TERM TREATMENT WITH ROMIPLOSTIM IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP).

EHA Library, Monica Carpenedo, 100909

LONG-TERM FOLLOW-UP SPLENECTOMY FOR IMMUN THROMBOPENIA PURPURA

EHA Library, Mohamed Bradai, 100910

WHOLE EXOME-SEQUENCING TO IDENTIFY GENETIC RISK FACTORS OF INHIBITOR IN KOREAN SEVERE HEMOPHILIA A PATIENTS

EHA Library, Kiyoung Yoo, 100911

SREENING FOR AN ACQUIRED VON WILLEBRAND SYNDROME IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Bozena Sokolowska, 100912

INTEREST OF A NEW RAPID COMMERCIAL ASSAY FOR THE ANALYSIS OF VON WILLEBRAND MULTIMERS IN AGAROSE GEL

EHA Library, Marc Vasse, 100913

DENGUE VIRUS NONSTRUCTURAL PROTEIN 1-INDUCED ANTIBODIES CROSS-REACT WITH HUMAN PLASMINOGEN AND ENHANCE ITS ACTIVATION

EHA Library, Trai-Ming Yeh, 100914

GENERAL DECREASE OF CIRCULATING MICROPARTICLES IS RELATED TO THE PRESENCE OF FVIII INHIBITORS IN HEMOPHILIA A PATIENTS

EHA Library, Amanda Silveira Cassette, 100915

MICROVESICLES ARE A POTENTIAL BIOMARKER FOR THROMBOSIS AND DIC IN ACUTE LEUKEMIC PATIENTS: A CROSS-SECTIONAL STUDY

EHA Library, Damien Gheldof, 100916

THERAPEUTIC APPROACH TOWARDS SYMPTOMATIC THROMBOCYTOPENIA IN DENGUE HEMORRHAGIC FEVER

EHA Library, Tahir Jameel, 100917

PREVALENCE AND PREDICTIVE MODEL OF MYELOPROLIFERATIVE NEOPLASM-RELEVANT MOLECULAR MARKERS IN ISCHEMIC STROKE PATIENTS,

EHA Library, Yi-Yang Chen, 100918

DENGUE VIRUS NON-STRUCTURAL PROTEIN 1 INDUCES VASCULAR LEAKAGE THROUGH MACROPHAGE MIGRATION INHIBITORY FACTOR SECRETION AND GLYCOCALYX DEGRADATION

EHA Library, Christina Hong-Ru Chen, 100919

PROVOKED VENOUS THROMBOEMBOLISM IN NON-CANCER PATIENTS: ARE THEY THE SAME?

EHA Library, Chong Chyn Chua, 100920

COAGULATION PROCESS AND FIBRINOGEN GENETIC VARIABILITY ARE STRONG RISK FACTORS FOR ATHEROGENESIS, MYOCARDIAL INFARCTION AND THE EXTEND OF THE DISEASE IN SUBJECTS SUSPECTED FOR STABLE ANGINA

EHA Library, Zoi Pallantza, 100921

LONGTERM CANCER RISK AFTER VENOUS THROMBOEMBOLISM

EHA Library, Lisbeth Eischer, 100922

POLYMORPHISM OF GENES INVOLVED IN LIPID METABOLISM AS A RISK FACTOR FOR VENOUS THROMBOEMBOLISM

EHA Library, Svetlana Svitina, 100923

HIGH LEVELS OF FIBRINOGEN, BUT NOT FIBRINOGEN GENETIC VARIANTS PREDICT CORONARY ARTERY DISEASE IN SUBJECTS WITH HYPERTENSION AND DIABETES MELLITUS TYPE 2

EHA Library, Zoi Pallantza, 100924

VENOUS THROMBOEMBOLISM IN NORTHEAST MELBOURNE, AUSTRALIA: EVALUATION OF EPIDEMIOLOGY, RISK FACTORS AND TREATMENT STRATEGIES IN THE WARFARIN ERA

EHA Library, Hui Yin Lim, 100925

RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF IDELALISIB (IDELA) IN COMBINATION WITH OFATUMUMAB (OFA) FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Timothy Dichiara, 101336

GADOLIN: PRIMARY RESULTS FROM A PHASE III STUDY OF OBINUTUZUMAB PLUS BENDAMUSTINE COMPARED WITH BENDAMUSTINE ALONE IN PATIENTS WITH RITUXIMAB-REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

EHA Library, Laurie Sehn, 101340

PRELIMINARY PHASE II RESULTS OF ARA-C AND IDARUBICIN IN COMBINATION WITH SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) COMPOUND SELINEXOR (KPT-330) IN PATIENTS WITH RELAPSED OR REFRACTORY AML

EHA Library, Anne Kranich, 101346

IN VITRO-GENERATED MYELOID-DERIVED SUPPRESSOR CELLS (MDSC) PREVENT MURINE GRAFT-VERSUS-HOST DISEASE (GVHD) BY INDUCING TYPE 2 T CELLS WITHOUT DISABLING ANTI-TUMOR CYTOTOXICITY

EHA Library, Gudrun Strauss, 103059

A LONGITUDINAL PROSPECTIVE STUDY EVALUATING THE EFFECTS OF ELTROMBOPAG (EPAG) TREATMENT ON BONE MARROW (BM) IN PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA: FINAL ANALYSIS

EHA Library, Uwe Platzbecker, 103062

BCR-ABL LEVELS AT LANDMARK TIMEPOINTS BETWEEN 1-3 YEARS OF IMATINIB ARE PREDICTIVE OF TIME TO A DEEP MOLECULAR RESPONSE AND CAN GUIDE THERAPY SWITCH DECISIONS WHERE TKI DISCONTINUATION IS THE GOAL

EHA Library, Susan Branford, 103075

A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) AND ANEMIA REQUIRING TRANSFUSION

EHA Library, Rami S. Komrokji, 103078

DASATINIB (DAS) IN COMBINATION WITH CHEMOTHERAPY AND AS MAINTENANCE IN CORE-BINDING FACTOR (CBF) ACUTE MYELOID LEUKEMIA (AML): A PHASE IB/IIA STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)

EHA Library, Peter Paschka, 103087

REGULATORY NETWORK GATA1-MEDIATED ON SEC23B GENE IN ERYTHROID CELLS

EHA Library, Roberta Russo, 103152